GT Biopharma SG&A Expense (TTM) Analysis

GT Biopharma Inc (GTBP)

2.88 +0.22 (+8.27%) USD | NASDAQ | Jul 02, 16:00

2.88 0.00 (0.00%) After-Hours: 05:43

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1992. Upgrade now.

Date	Value
March 31, 2024	7.409M
December 31, 2023	7.11M
September 30, 2023	8.235M
June 30, 2023	10.76M
March 31, 2023	11.11M
December 31, 2022	12.45M
September 30, 2022	21.38M
June 30, 2022	22.05M
March 31, 2022	23.92M
December 31, 2021	47.92M
September 30, 2021	38.01M
June 30, 2021	35.09M
March 31, 2021	32.90M
December 31, 2020	6.279M
September 30, 2020	5.179M
June 30, 2020	6.735M
March 31, 2020	7.314M
December 31, 2019	9.79M
September 30, 2019	10.79M
June 30, 2019	12.24M
March 31, 2019	12.02M
December 31, 2018	12.49M
September 30, 2018	16.36M
June 30, 2018	137.66M
March 31, 2018	136.80M

Date	Value
December 31, 2017	134.50M
September 30, 2017	129.34M
June 30, 2017	5.29M
March 31, 2017	6.117M
December 31, 2016	8.399M
September 30, 2016	10.21M
June 30, 2016	10.48M
March 31, 2016	10.06M
December 31, 2015	7.954M
September 30, 2015	7.211M
June 30, 2015	5.206M
March 31, 2015	3.867M
December 31, 2014	2.40M
September 30, 2014	1.011M
June 30, 2014	0.664M
March 31, 2014	0.67M
December 31, 2013	0.935M
September 30, 2013	1.581M
June 30, 2013	2.819M
March 31, 2013	3.732M
December 31, 2012	3.763M
September 30, 2012	3.949M
June 30, 2012	3.046M
March 31, 2012	2.454M
December 31, 2011	3.889M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

5.179M

Minimum

Sep 2020

47.92M

Maximum

Dec 2021

17.07M

Average

10.79M

Median

Sep 2019

SG&A Expense (TTM) Benchmarks